newsfilter
← Latest News
GlobeNewswire·

Ensysce Biosciences' Covistat Subsidiary "At Home Coronavirus Pill" Commencing to Phase 2 clinical development

NEW YORK and SAN DIEGO, May 07, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. ("Ensysce"), which has entered into an agreement for a business combination with Leisure Acquisition Corp. ("LACQ") (NASDAQ:LACQ, LACQU, LACQW))), a special purpose acqu